The phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) axis orchestrates key processes in cellular metabolism, growth, and survival, and constitutes a central oncogenic driver across multiple tumor types. This evidence concerns the gene AKT1 and neoplasm.